CORBIN STRATEGIES LLC

Lobbying for BOBBIE BABY, INC. · Infant formula company

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Sep 22, 2026.

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 4

Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

S 272
Protect Infant Formula from Contamination Act
HR 2008
Infant Formula Made in America Act of 2025

Lobbying activity 4

Agriculture

Advocate for issues related to infant formula, including improving access, improving nutrition standards for infants, and growing manufacturing opportunities for small domestic infant formula producers.

Health Issues

Advocate for issues related to infant formula, including maternal health issues, improving affordable access to formula, improving nutrition standards for infants (Protect Infant Formula from Contamination Act - S.272), and growing manufacturing opportunities for small domestic infant formula producers.

Budget/Appropriations

Advocate for appropriations to address infant formula production and related issues.

Taxation/Internal Revenue Code

Advocate for infant formula manufacturing tax credits (Infant Formula Made In America Act - H.R.2008).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.